Oh great. New drugs, new problems.The title of the article says "may cause" but in the body it says the warning states "the FDA recently issued a drug safety warning on the possibility of diabetic ketoacidosis (DKA) in all people taking SGLT-2 inhibitor pills."
What drugs are impacted by this warning?
The warning applies to the following US approved drugs:
SGLT-2 inhibitors: Invokana, Farxiga, and Jardiance
Combination drugs: Invokamet, Xigduo XR, and Glyxambi.
SGLT-2 inhibitors are approved for type 2 diabetes, though some type 1 patients have taken them off-label in addition to insulin to help stabilize blood sugar levels and reduce their insulin requirements.
- See more at: http://diatribe.org/fda-issues-safety-stateme...
If you are using any of these medications, I would say talk to your doctor and get tested to make sure the risk is worth the treatment.
Next Discussion: Timesulin Pen Cap »